Cystic fibrosis. Lung Biology in Health Disease, Vol. 242.

Kotsimbos T.

Source: Eur Respir Rev 2010 19: 352-353
Journal Issue: December 2010 - 19 (118)

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Kotsimbos T.. Cystic fibrosis. Lung Biology in Health Disease, Vol. 242.. Eur Respir Rev 2010 19: 352-353

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Interventional Pulmonary Medicine. Lung Biology in Health and Disease
Source: Eur Respir J 2005; 25: 583
Year: 2005


A review of Lung Transplantation for Cystic Fibrosis in Ireland in 2017.
Source: International Congress 2018 – Cystic fibrosis in adults: current research
Year: 2018


Singing for Lung Health: Evaluation of the British Lung Foundation programme.
Source: International Congress 2018 – Chronic respiratory disease: respiratory muscle function, breathing exercises and airway clearance techniques
Year: 2018

Mapping the future for pulmonary fibrosis: report from the 17th International Colloquium on Lung and Airway Fibrosis
Source: Eur Respir J 2013; 42: 230-238
Year: 2013



Call for papers on cystic fibrosis: a collaborative research session featuring the European Respiratory Journal, The Lancet Respiratory Medicine and the Journal of Cystic Fibrosis
Source: Eur Respir J, 54 (6) 1960001; 10.1183/13993003.60001-2019
Year: 2019



ERS International Congress, Madrid, 2019: highlights from the Interstitial Lung Diseases Assembly
Source: ERJ Open Res, 6 (4) 00143-2020; 10.1183/23120541.00143-2020
Year: 2020



Clinical characteristics of familial Idiopathic Pulmonary Fibrosis (f-IPF) at the University of Giessen Marburg Lung Center.
Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Year: 2018


GPs Meet Rare Lung Disorders Task Force factsheet: cystic fibrosis
Source: Breathe 2014; 10:345-347
Year: 2014


The incidence of Progressive Fibrotic Interstitial Lung Diseases (PFILD) treatable with oral-antifibrotic therapy in a UK Specialist Interstitial Lung Disease clinic.
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020


Oxford Respiratory Medicine Library: Cystic Fibrosis
Source: Breathe 2015; 11: 313
Year: 2015


Clinical picture analysis of idiopathic pulmonary fibrosis (IPF) and lung cancer (LC) concomitance in the population of patients hospitalized in Ist Clinic of Lung Diseases Institute for Tuberculosis and Lung Diseases in Warsaw, Poland in the years 1994-2009
Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis?
Year: 2011


Lung Cancer Screening Programs: a missed “window” to diagnose Obstructive Lung Disease. The NLST-ACRIN experience.
Source: International Congress 2018 – Interdependence of COPD and comorbidities and the underlying mechanisms
Year: 2018




DANILDA – The First Danish National Interstitial Lung Disease Registry
Source: International Congress 2019 – Interstitial lung disease registries
Year: 2019

The European research collaboration for Children's Interstitial Lung Disease (ChILDEU) ERS Clinical Research Collaboration
Source: Eur Respir J, 52 (6) 1801855; 10.1183/13993003.01855-2018
Year: 2018



Case Series of COVID-19 Disease in Pediatric Chronic Lung Diseases
Source: Virtual Congress 2021 – Paediatric respiratory infections: chronic infection, vaccination and lung function
Year: 2021


The Italian Reference Center Database for Pulmonary Alveolar Proteinosis (PAP).
Source: International Congress 2017 – Rare diseases
Year: 2017


Effect of the Liverpool Healthy Lung Programme on Outcomes in Lung Cancer
Source: Virtual Congress 2020 – Screening and early lung cancer
Year: 2020


European Cystic Fibrosis Society Clinical Trials Network (ECFS-CTN): structure and impact since 2009
Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis
Year: 2020